logo
Select company
Select metric
53.32%Stock Based Compensation Margin
VS
Market
7
Sector
26
Industry
48
History
80
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Stock Based Compensation Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - SB Comp % Historical data
DateRevenuesStock Based CompensationStock Based Compensation Margin
6/30/2025$ 15.42M$ 8.22M53.32%
3/31/2025$ 6.4M$ 10.54M164.55%
12/31/2024$ 6.17M$ 8.99M145.62%
9/30/2024$ 6.74M$ 9.08M134.63%
6/30/2024$ 10.06M$ 9.4M93.43%
3/31/2024$ 12.99M$ 9.18M70.72%
12/31/2023$ 18.14M$ 9.3M51.27%
9/30/2023$ 22.24M$ 9.24M41.57%
6/30/2023$ 23.54M$ 8.48M36.02%
3/31/2023$ 33.13M$ 7.58M22.87%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) SB Comp % stands at 76.59%.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average SB Comp % has been 67.6%.
  • The median SB Comp % for ARBUTUS BIOPHARMA CORP during this period was 60.82%
  • ARBUTUS BIOPHARMA CORP reached its highest SB Comp % over the past 5 years at 164.55%.
  • The lowest SB Comp % recorded by ARBUTUS BIOPHARMA CORP in the same timeframe 18.41%

ARBUTUS BIOPHARMA CORP's SB Comp % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

SB Comp % Benchmarks
CompanySB Comp %
ZBIO : ZENAS BIOPHARMA INC 131.79%QURE : UNIQURE NV 123.32%NUVB : NUVATION BIO INC 261.58%VIR : VIR BIOTECHNOLOGY INC 310.78%BCYC : BICYCLE THERAPEUTICS PLC 200.07%IMNM : IMMUNOME INC 170.08%RLAY : RELAY THERAPEUTICS INC 884.92%CAPR : CAPRICOR THERAPEUTICS INC 102.55%ALMS : ALUMIS INC 195.95%TSHA : TAYSHA GENE THERAPIES INC 161.24%

Definition of Stock Based Compensation Margin

[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for ARBUTUS BIOPHARMA CORP is calculated as follows: SB Comp. [ $ 4.71M ] / Revenues [ $ 6.15M ]
(=) SB Comp % [ 76.59% ]

ABUS - Stock Based Compensation Margin, Last 5 years

18.41%

Minimum

Dec 31, 2022

164.55%

Maximum

Mar 31, 2025

67.6%

Average

60.82%

Median

SB Comp % Benchmark Analysis

The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
filtered constituents2.99K
min-3.97%
max8.43%
average1.72%
median1.04%
std1.9%